Table 2.

Effect of estrogen and related compounds on the release of [3H]AEA from HUVECs preloaded with [3H]AEA

Sample[3H]AEA release, % control
Control 100* 
+100 nM E2 600 ± 60 
+100 nM E2+100 nM TMX 105 ± 10 
+100 nM E2+100 nM ICI182780 580 ± 58 
+100 nM E2+2 μM SR141716 520 ± 52 
+100 nM E2+100 nM HU-210 950 ± 95,2-153 
+100 nM E2+2 μM CBD 585 ± 58 
+100 nM E2+2 μM CAPS 600 ± 60 
+100 nM E2+10 μM AM404 150 ± 15 
+100 nM E2+400 μMl-NAME 160 ± 16 
+100 nM E2+50 μM EGTA-am 150 ± 15 
Sample[3H]AEA release, % control
Control 100* 
+100 nM E2 600 ± 60 
+100 nM E2+100 nM TMX 105 ± 10 
+100 nM E2+100 nM ICI182780 580 ± 58 
+100 nM E2+2 μM SR141716 520 ± 52 
+100 nM E2+100 nM HU-210 950 ± 95,2-153 
+100 nM E2+2 μM CBD 585 ± 58 
+100 nM E2+2 μM CAPS 600 ± 60 
+100 nM E2+10 μM AM404 150 ± 15 
+100 nM E2+400 μMl-NAME 160 ± 16 
+100 nM E2+50 μM EGTA-am 150 ± 15 
*

100% = 320 ± 30 fmol/106 cells.

P < .01 and P < .05 compared with control.

P < .01 compared with E2.

F2-153

P < .05 compared with E2.

P > .05 in all other cases.

or Create an Account

Close Modal
Close Modal